Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 352934, 13 pages
http://dx.doi.org/10.1155/2015/352934
Research Article

Age-Related Differences in Percentages of Regulatory and Effector T Lymphocytes and Their Subsets in Healthy Individuals and Characteristic STAT1/STAT5 Signalling Response in Helper T Lymphocytes

1Department of Allergology, Rheumatology and Clinical Immunology, University Children’s Hospital, University Medical Centre Ljubljana, Bohoričeva 20, SI-1525 Ljubljana, Slovenia
2Department of Laboratory Diagnostics, University Medical Centre Maribor, Ljubljanska Ulica 5, SI-2000 Maribor, Slovenia
3Faculty of Medicine, University of Maribor, Taborska Ulica 8, SI-2000 Maribor, Slovenia
4Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, SI-1000 Ljubljana, Slovenia
5Department of Pediatrics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000 Ljubljana, Slovenia

Received 29 March 2015; Revised 6 August 2015; Accepted 27 August 2015

Academic Editor: Aurelia Rughetti

Copyright © 2015 Marija Holcar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Gillis and P. Loughlan, “Not just small adults: the metaphors of paediatrics,” Archives of Disease in Childhood, vol. 92, no. 11, pp. 946–947, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Caruso, S. Buffa, G. Candore et al., “Mechanisms of immunosenescence,” Immunity & Ageing, vol. 6, article 10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Vasto and C. Caruso, “Immunity & Ageing: a new journal looking at ageing from an immunological point of view,” Immunity & Ageing, vol. 1, article 1, 4 pages, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. O. O. Onyema, R. Njemini, I. Bautmans, W. Renmans, M. D. Waele, and T. Mets, “Cellular aging and senescence characteristics of human T-lymphocytes,” Biogerontology, vol. 13, no. 2, pp. 169–181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. L. Torres, A. L. D. Angelo, M. O. Silva et al., “Establishing the reference range for T lymphocytes subpopulations in adults and children from Brazil,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 55, no. 5, pp. 323–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. García-Dabrio, N. Pujol-Moix, Á. Martinez-Perez et al., “Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish gait-2 study,” Acta Haematologica, vol. 127, no. 4, pp. 244–249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. H. Schatorjé, E. F. A. Gemen, G. J. A. Driessen, J. Leuvenink, R. W. N. M. van Hout, and E. de Vries, “Paediatric reference values for the peripheral T cell compartment,” Scandinavian Journal of Immunology, vol. 75, no. 4, pp. 436–444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Salam, S. Rane, R. Das et al., “T cell ageing: effects of age on development, survival & function,” Indian Journal of Medical Research, vol. 138, no. 5, pp. 595–608, 2013. View at Google Scholar · View at Scopus
  9. J. Yan, J. M. Greer, R. Hull et al., “The effect of ageing on human lymphocyte subsets: comparison of males and females,” Immunity and Ageing, vol. 7, article 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Crispín, M. Oukka, G. Bayliss et al., “Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys,” The Journal of Immunology, vol. 181, no. 12, pp. 8761–8766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Yachie, Y. Ueno, and N. Takano, “Developmental changes of double-negative (CD3+ 48) T cells in human peripheral blood,” Clinical & Experimental Immunology, vol. 76, no. 4, pp. 258–261, 1989. View at Google Scholar
  12. J. A. Tarbox, M. P. Keppel, N. Topcagic et al., “Elevated double negative T cells in pediatric autoimmunity,” Journal of Clinical Immunology, vol. 34, no. 5, pp. 594–599, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Alam, D. Goldeck, A. Larbi, and G. Pawelec, “Aging affects the proportions of T and B cells in a group of elderly men in a developing country—a pilot study from Pakistan,” Age, vol. 35, no. 5, pp. 1521–1530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Sandmand, H. Bruunsgaard, K. Kemp et al., “Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?” Clinical & Experimental Immunology, vol. 127, no. 1, pp. 107–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gosselin, P. Monteiro, N. Chomont et al., “Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection,” Journal of Immunology, vol. 184, no. 3, pp. 1604–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Purnama, X. Camous, and A. Larbi, “An overview of T cell subsets and their potential use as markers of immunological ageing,” International Trends in Immunity, vol. 1, no. 4, pp. 21–32, 2013. View at Google Scholar
  17. L. Maggi, V. Santarlasci, M. Capone et al., “CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC,” European Journal of Immunology, vol. 40, no. 8, pp. 2174–2181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. F. Zambrano-Zaragoza, E. J. Romo-Martínez, M. d. Durán-Avelar, N. García-Magallanes, and N. Vibanco-Pérez, “Th17 cells in autoimmune and infectious diseases,” International Journal of Inflammation, vol. 2014, Article ID 651503, 12 pages, 2014. View at Publisher · View at Google Scholar
  19. S. K. Lee, J. Y. Kim, S. E. Hur et al., “An imbalance in interleukin-17-producing T and Foxp3+ regulatory T cells in women with idiopathic recurrent pregnancy loss,” Human Reproduction, vol. 26, no. 11, pp. 2964–2971, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Orsini, A. Legitimo, A. Failli, F. Massei, P. Biver, and R. Consolini, “Enumeration of human peripheral blood dendritic cells throughout the life,” International Immunology, vol. 24, no. 6, pp. 347–356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Miyara, G. Gorochov, M. Ehrenstein, L. Musset, S. Sakaguchi, and Z. Amoura, “Human FoxP3+ regulatory T cells in systemic autoimmune diseases,” Autoimmunity Reviews, vol. 10, no. 12, pp. 744–755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. I. Arismendi, E. G. Kallás, B. A. N. dos Santos, M. M. S. Carneiro-Sampaio, and C. Kayser, “Thymopoiesis and regulatory T cells in healthy children and adolescents,” Clinics, vol. 67, no. 5, pp. 425–429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. K.-M. Chavele and M. R. Ehrenstein, “Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis,” FEBS Letters, vol. 585, no. 23, pp. 3603–3610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. N. E. Aerts, E. J. Dombrecht, D. G. Ebo, C. H. Bridts, W. J. Stevens, and L. S. De Clerck, “Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis,” Cellular Immunology, vol. 251, no. 2, pp. 109–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Zhang, X. Zhang, F. L. Tang, L. P. Zhu, Y. Liu, and P. E. Lipsky, “Clinical significance of increased CD4+CD25Foxp3+ T cells in patients with new-onset systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 1037–1040, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Bonelli, L. Göschl, S. Blüml et al., “CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis?” Arthritis Research and Therapy, vol. 16, no. 2, article R104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Nishioka, J. Shimizu, R. Iida, S. Yamazaki, and S. Sakaguchi, “CD4+CD25+Foxp3+ T cells and CD4+CD25Foxp3+ T cells in aged mice,” The Journal of Immunology, vol. 176, no. 11, pp. 6586–6593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Rani, R. Greenlaw, M. Runglall, S. Jurcevic, and S. John, “FRA2 Is a STAT5 target gene regulated by il-2 in human CD4 T cells,” PLoS ONE, vol. 9, no. 2, Article ID e90370, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. Goronzy, G. Li, M. Yu, and C. M. Weyand, “Signaling pathways in aged T cells—a reflection of T cell differentiation, cell senescence and host environment,” Seminars in Immunology, vol. 24, no. 5, pp. 365–372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Siebler, S. Wirtz, S. Klein et al., “A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation,” Hepatology, vol. 38, no. 6, pp. 1573–1580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Schreiber, P. Rosenstiel, J. Hampe et al., “Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease,” Gut, vol. 51, no. 3, pp. 379–385, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Fulop, A. Larbi, N. Douziech, I. Levesque, A. Varin, and G. Herbein, “Cytokine receptor signalling and aging,” Mechanisms of Ageing and Development, vol. 127, no. 6, pp. 526–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. K.-I. Matsuoka, J. Koreth, H. T. Kim et al., “Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease,” Science Translational Medicine, vol. 5, no. 179, Article ID 179ra43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. D. Waight, D. Banik, E. A. Griffiths, M. J. Nemeth, and S. I. Abrams, “Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia,” The Journal of Biological Chemistry, vol. 289, no. 22, pp. 15642–15652, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Garrigan, N. S. Belkin, J. J. Alexander et al., “Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in type 1 diabetic human monocytes,” PLoS ONE, vol. 8, no. 10, Article ID e76919, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Trapecar, A. Goropevsek, M. Gorenjak, L. Gradisnik, and M. S. Rupnik, “A co-culture model of the developing small intestine offers new insight in the early immunomodulation of enterocytes and macrophages by Lactobacillus spp. through STAT1 and NF-kB p65 translocation,” PLoS ONE, vol. 9, no. 1, Article ID e86297, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. T. C. George, S. L. Fanning, P. Fitzgeral-Bocarsly et al., “Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow,” Journal of Immunological Methods, vol. 311, no. 1-2, pp. 117–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. W. Cotari, G. Voisinne, O. E. Dar et al., “Dissecting common γ chain cytokine family signaling in T cells using cell-to-cell variability analysis,” Science Signallng, vol. 6, no. 266, pp. 1–18, 2014. View at Google Scholar
  39. K. L. Gibson, Y.-C. Wu, Y. Barnett et al., “B-cell diversity decreases in old age and is correlated with poor health status,” Aging Cell, vol. 8, no. 1, pp. 18–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Al-Mawali, A. D. Pinto, R. Al Busaidi, and I. Al-Zakwani, “Lymphocyte subsets: reference ranges in an age- and gender-balanced population of Omani healthy adults,” Cytometry A, vol. 83, no. 8, pp. 739–744, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Osugi, J. Hara, H. Kurahashi et al., “Age-related changes in surface antigens on peripheral lymphocytes of healthy children,” Clinical & Experimental Immunology, vol. 100, no. 3, pp. 543–548, 1995. View at Google Scholar · View at Scopus
  42. W. S. Wong, A. W. I. Lo, L. P. Siu et al., “Reference ranges for lymphocyte subsets among healthy Hong Kong Chinese adults by single-platform flow cytometry,” Clinical and Vaccine Immunology, vol. 20, no. 4, pp. 602–606, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. M. Q. M. C. Tavares, W. D. L. B. Junior, and M. R. Lopes e Silva, “Normal lymphocyte immunophenotype in an elderly population,” Revista Brasileira de Hematologia e Hemoterapia, vol. 36, no. 3, pp. 180–183, 2014. View at Publisher · View at Google Scholar
  44. S. Q. Crome, B. Clive, A. Y. Wang et al., “Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells,” The Journal of Immunology, vol. 185, no. 6, pp. 3199–3208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Annunziato, L. Cosmi, V. Santarlasci et al., “Phenotypic and functional features of human Th17 cells,” The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Miyara, Y. Yoshioka, A. Kitoh et al., “Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor,” Immunity, vol. 30, no. 6, pp. 899–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. E. R. R. Dal Ben, C. H. do Prado, T. S. A. Baptista, M. E. Bauer, and H. L. Staub, “Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome,” Journal of Clinical Immunology, vol. 33, no. 4, pp. 876–879, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Kshirsagar, E. Binder, M. Riedl, G. Wechselberger, E. Steichen, and M. Edelbauer, “Enhanced activity of Akt in Teff cells from children with lupus nephritis is associated with reduced induction of tumor necrosis factor receptor-associated factor 6 and increased OX40 expression,” Arthritis and Rheumatism, vol. 65, no. 11, pp. 2996–3006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. E. Morgan, J. H. M. van Bilsen, A. M. Bakker et al., “Expression of FOXP3 mRNA is not confined to CD4+ CD25+ T regulatory cells in humans,” Human Immunology, vol. 66, no. 1, pp. 13–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Wang, A. Ioan-Facsinay, E. I. H. van der Voort, T. W. J. Huizinga, and R. E. M. Toes, “Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells,” European Journal of Immunology, vol. 37, no. 1, pp. 129–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Mina and H. I. Brunner, “Pediatric lupus—are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?” Rheumatic Disease Clinics of North America, vol. 36, no. 1, pp. 53–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. L. B. Ivashkiv and X. Hu, “Signaling by STATs,” Arthritis Research & Therapy, vol. 6, no. 4, pp. 159–168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Hu and L. B. Ivashkiv, “Cross-regulation of signaling and immune responses by IFN-gamma and STAT1,” Immunity, vol. 31, no. 4, pp. 539–550, 2009. View at Google Scholar
  54. W. Sheng, F. Yang, Y. Zhou et al., “STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation,” Cell Research, vol. 24, no. 12, pp. 1387–1402, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Golding, A. Rosen, M. Petri, E. Akhter, and F. Andrade, “Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses,” Immunology, vol. 131, no. 1, pp. 107–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. T. B. Niewold, J. E. Adler, S. B. Glenn, T. J. A. Lehman, J. B. Harley, and M. K. Crow, “Age- and sex-related patterns of serum interferon-α activity in lupus families,” Arthritis & Rheumatism, vol. 58, no. 7, pp. 2113–2119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. D. M. Longo, B. Louie, S. Putta et al., “Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activation,” The Journal of Immunology, vol. 188, no. 4, pp. 1717–1725, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. W. Liao, J.-X. Lin, and W. J. Leonard, “IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation,” Current Opinion in Immunology, vol. 23, no. 5, pp. 598–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Yamane and W. E. Paul, “Cytokines of the γc family control CD4+ T cell differentiation and function,” Nature Immunology, vol. 13, no. 11, pp. 1037–1044, 2012. View at Publisher · View at Google Scholar · View at Scopus